Survival of AIDS patients with primary central nervous system lymphoma may be improved by the radiosensitizing effects of highly active antiretroviral therapy.
Pajonk
Frank
F
McBride
William H
WH
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000201:enzymology; D023241:Antiretroviral Therapy, Highly Active; D016543:Central Nervous System Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D015996:Survival Rate
D017320:HIV Protease Inhibitors; D011838:Radiation-Sensitizing Agents